godlovesatrier
Senior Member
- Messages
- 2,616
- Location
- United Kingdom
I can't see this on the forum but if mods can remove this thread if it's already known to exist that would be great.
So it's only a theory but in 2017 Naviaux did a presentation with the help of the OMF about metabolic root cause and how it effects ME, with a specific presentation on how the Suramin drug worked in the autism trial. I found this very interesting as an adjunct to Suramin's ability to block CDR response in cells.
Full presentation here:
And here an explanation for how Suramin worked in the autistic trial and could have the same benefit in ME/CFS patients:
Naviaux is conducting another study this year 2020 with a 100 large cohort of autistic children to duplicate his original findings. He says they did the original trial to also prove that the drug was safe to use. He also states that only one dose was required to get the benefit.
I don't believe Naivaux is looking to do a ME/CFS Suramin trial until possibly 2021.
Hopefully this is useful to anyone interested in Suramin.
So it's only a theory but in 2017 Naviaux did a presentation with the help of the OMF about metabolic root cause and how it effects ME, with a specific presentation on how the Suramin drug worked in the autism trial. I found this very interesting as an adjunct to Suramin's ability to block CDR response in cells.
Full presentation here:
And here an explanation for how Suramin worked in the autistic trial and could have the same benefit in ME/CFS patients:
Naviaux is conducting another study this year 2020 with a 100 large cohort of autistic children to duplicate his original findings. He says they did the original trial to also prove that the drug was safe to use. He also states that only one dose was required to get the benefit.
I don't believe Naivaux is looking to do a ME/CFS Suramin trial until possibly 2021.
Hopefully this is useful to anyone interested in Suramin.